Imugene Ltd (ILA) Stock Price & News

All values in AUD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	402.86K	402.86K	640.19K	640.19K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	15.25M	15.25M	22.54M	22.54M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.24M	4.24M	11.69M	11.69M
Operating expense	19.49M	19.49M	34.23M	34.23M
Total operating expenses	19.49M	19.49M	34.23M	34.23M
Operating income	-19.08M	-19.08M	-33.59M	-33.59M
Other non operating income	-	-	-	-
EBT including unusual items	-18.91M	-18.91M	-33.76M	-33.76M
EBT excluding unusual items	-18.92M	-18.92M	-33.76M	-33.76M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-18.91M	-18.91M	-33.76M	-33.76M
Net profit margin	-4,693.96%	-4,693.96%	-5,273.16%	-5,273.16%
Earnings per share	-	-	-	-
Interest and investment income	201.44K	201.44K	44.64K	44.64K
Interest expense	-19.73K	-19.73K	-43.01K	-43.01K
Net interest expenses	181.70K	181.70K	1.64K	1.64K
Depreciation and amortization charges	-	-	-	-
EBITDA	-13.63M	-13.63M	-30.86M	-32.23M
Gain or loss from assets sale	-	-	-5.99K	-5.99K

Finance